Type 2 diabetes mellitus is associated with increased axial bone density in men and women from the Hertfordshire Cohort Study: evidence for an indirect effect of insulin resistance?

被引:207
作者
Dennison, EM [1 ]
Syddall, HE [1 ]
Sayer, AA [1 ]
Craighead, S [1 ]
Phillips, DIW [1 ]
Cooper, C [1 ]
机构
[1] Univ Southampton, Southampton Gen Hosp, MRC, Epidemiol Resource Ctr, Southampton SO16 6YD, Hants, England
基金
英国医学研究理事会;
关键词
bone density; diabetes; insulin;
D O I
10.1007/s00125-004-1560-y
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Aims/hypothesis. Previous studies have suggested that the high bone density often observed in type 2 diabetic patients may be explained by insulin resistance. We explored this hypothesis in the Hertfordshire Cohort Study. Methods. A total of 465 men and 444 women aged 59 to 71 years and with no prior diagnosis of diabetes attended a clinic where a glucose tolerance test was performed and bone density measured at the femoral neck and lumbar spine. Biochemical markers of bone turnover (serum osteocalcin and urinary mean c-terminal cross-linking telopeptide of type 11 collagen) were measured in 163 men. Results. According to WHO criteria, 83 men and 134 women were diagnosed with impaired glucose tolerance and a further 33 men and 32 women were diagnosed as having type 2 diabetes. Bone density was higher in newly diagnosed diabetic subjects, with relationships stronger in women (p<0.001) than men (p<0.05) and attenuated by adjustment for body mass index. In both sexes, we observed positive correlations between the total femur and femoral neck bone mineral density with measures of insulin resistance (r=0.17-0.22), with stronger results observed in women. These relationships did not apply after adjustment for body mass index. Glucose status did not lead to differences in osteocalcin level or c-terminal cross-linking telopeptide of type 11 collagen levels. Conclusions/interpretation. Our findings suggest that hyperinsulinaemia may affect bone mineral density through indirect effects, e.g. body weight.
引用
收藏
页码:1963 / 1968
页数:6
相关论文
共 19 条
[1]
Evaluation of bone turnover in postmenopausal patients with type 2 diabetes mellitus using biochemical markers and bone mineral density measurements [J].
Akin, O ;
Göl, K ;
Aktürk, M ;
Erkaya, S .
GYNECOLOGICAL ENDOCRINOLOGY, 2003, 17 (01) :19-29
[2]
ARDEN NK, 2004, IN PRESS PAEDIAT PER
[3]
BARRETTCONNOR E, 1992, JAMA-J AM MED ASSOC, V268, P3333
[4]
FACTORS ASSOCIATED WITH APPENDICULAR BONE MASS IN OLDER WOMEN [J].
BAUER, DC ;
BROWNER, WS ;
CAULEY, JA ;
ORWOLL, ES ;
SCOTT, JC ;
BLACK, DM ;
TAO, JL ;
CUMMINGS, SR .
ANNALS OF INTERNAL MEDICINE, 1993, 118 (09) :657-665
[5]
LEVELS OF CUSTOMARY PHYSICAL-ACTIVITY AMONG THE OLD AND THE VERY OLD LIVING AT HOME [J].
DALLOSSO, HM ;
MORGAN, K ;
BASSEY, EJ ;
EBRAHIM, SBJ ;
FENTEM, PH ;
ARIE, THD .
JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 1988, 42 (02) :121-127
[6]
Cigarette smoking and bone mineral density in the elderly [J].
Egger, P ;
Duggleby, S ;
Hobbs, R ;
Fall, C ;
Cooper, C .
JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 1996, 50 (01) :47-50
[7]
El Miedany YM, 1999, CLIN EXP RHEUMATOL, V17, P561
[8]
Associations among disease conditions, bone mineral density, and prevalent vertebral deformities in men and women 50 years of age and older: Cross-sectional results from the Canadian Multicentre Osteoporosis Study [J].
Hanley, DA ;
Brown, JP ;
Tenenhouse, A ;
Olszynski, WP ;
Ioannidis, G ;
Berger, C ;
Prior, JC ;
Pickard, L ;
Murray, TM ;
Anastassiades, T ;
Kirkland, S ;
Joyce, C ;
Joseph, L ;
Papaionnou, A ;
Jackson, SA ;
Poliquin, S ;
Adachi, JD .
JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 (04) :784-790
[9]
Lifestyle factors are associated with osteoporosis in lean women but not in normal and overweight women:: a population-based cohort study of 1222 women [J].
Korpelainen, R ;
Korpelainen, J ;
Heikkinen, J ;
Väänänen, K ;
Keinänen-Kiukaanniemi, S .
OSTEOPOROSIS INTERNATIONAL, 2003, 14 (01) :34-43
[10]
Diabetes mellitus a risk for osteoporosis? [J].
Leidig-Bruckner, G ;
Ziegler, R .
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2001, 109 :S493-S514